(1)
Umbilical Cord Tissue-Derived Mesenchymal Stem Cells Should Be Considered As Adjuvant Therapy for COVID-19 Treatment: An Opinion from Pooled Clinical Evidence. Biomed. Res. Ther. 2021, 8 (9), 4583-4595. https://doi.org/10.15419/bmrat.v8i9.694.